[PDF][PDF] Quetiapine for patients with agitation or psychosis related to Alzheimer's disease and vascular dementia
… medications with antipsychotic agents prescribed from neurology or psychiatry departments
during 2006 and 2007. Eligibility of candidate … switch antipsychotics if the treatment doesn’t …
during 2006 and 2007. Eligibility of candidate … switch antipsychotics if the treatment doesn’t …
将脂肪酸酰胺水解酶抑制与过氧化物酶体增殖物活化受体活化相结合: 一种新的潜在的多靶点治疗策略, 用于治疗阿尔茨海默病
L Brunetti, A Laghezza, F Loiodice… - 中国神经再生研究 …, 2020 - sjzsyj.com.cn
… therapeutic strategy for the treatment of Alzheimer’s disease Alzheimer’s disease (AD) is a
… -functional therapeutic agents, none of the candidate drugs is even close to be introduced in …
… -functional therapeutic agents, none of the candidate drugs is even close to be introduced in …
天然膳食化合物作为抗阿尔茨海默病药物的遗传和表观遗传靶标
WO Castillo-Ordoñez, N Cajas-Salazar… - 中国神经再生研究 …, 2024 - sjzsyj.com.cn
… effects of a few Alzheimer’s disease-related genes. … of some natural compounds in the
prevention and treatment of AD. … Most central nervous system drug candidates cannot penetrate …
prevention and treatment of AD. … Most central nervous system drug candidates cannot penetrate …
基于脂质体的药物递送作为阿尔茨海默病的潜在治疗选择
C Hernandez, S Shukla - 中国神经再生研究(英文版), 2022 - sjzsyj.com.cn
… drug delivery to the brain, and how liposomal drug delivery can play an important role as a
drug delivery method for the treatment of Alzheimer’s disease. This review also sheds some …
drug delivery method for the treatment of Alzheimer’s disease. This review also sheds some …
阿尔茨海默病的钙信号靶向: 挑战和有前途的治疗途径
LL Song, YP Tang, BYK Law - 中国神经再生研究(英文版), 2024 - sjzsyj.com.cn
… Currently, the majority of candidate compounds for AD are developed via targeting Aβ, tau,
… drugs that can target the disease. Currently, the treatment for AD is limited only to a few orally …
… drugs that can target the disease. Currently, the treatment for AD is limited only to a few orally …
游离泛素: 神经退行性疾病的新型治疗靶点
CW Park, KY Ryu - 中国神经再生研究(英文版), 2021 - sjzsyj.com.cn
… drugs targeting AD merely delay the progression of the disease, without providing a bona
fide treatment… of free Ub above certain levels may be a good candidate for a therapeutic …
fide treatment… of free Ub above certain levels may be a good candidate for a therapeutic …
使用我们的迷你脑: 脑类器官作为人类朊病毒病的改进细胞模型
BR Groveman, R Walters, CL Haigh - 中国神经再生研究(英文版), 2020 - sjzsyj.com.cn
… is available for any of these diseases and treatment is based … reason for the failures of drug
candidates in human trials but, … to model Alzheimer’s disease, Parkinson’s disease, Down’s …
candidates in human trials but, … to model Alzheimer’s disease, Parkinson’s disease, Down’s …
陶氏症治疗方法的新见解
… result for the treatment of tauopathies and Alzheimer’s disease in … of potential drug candidates
for the treatment of tauopathies. … advances over the last few years with the approval of ASO …
for the treatment of tauopathies. … advances over the last few years with the approval of ASO …
非神经元细胞中未折叠的p53 支持阿尔茨海默病的细菌病因
PW French - 中国神经再生研究(英文版), 2022 - sjzsyj.com.cn
… Alzheimer’s disease has proven to be largely intractable to … biomarkers have been suggested
as candidates for an early, pre… Given that drug-based treatment options are currently very …
as candidates for an early, pre… Given that drug-based treatment options are currently very …
阿尔茨海默病中的小分子诱饵
… Recent progress in the treatment of Alzheimer’s disease (AD) … In a series of small molecules,
we identified candidates that … and to win against this scourge will require treatments that …
we identified candidates that … and to win against this scourge will require treatments that …